CADY LAWS: Open Payments
NPI 1104116102 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$724 in 35 payments from 13 companies in 2025. Trend: 2023 $281 · 2024 $195 · 2025 $724
Food & beverage: $724
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $107 |
| W. L. Gore & Associates, Inc. | 3 | $88 |
| Teva Pharmaceuticals USA, Inc. | 4 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Neurocrine BioSciences, Inc. | 3 | $61 |
| Janssen Pharmaceuticals, Inc | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 3 | $43 |
| Alkermes, Inc. | 2 | $38 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, INVEGA SUSTENNA, UZEDY, TRINTELLIX, Auvelity, REXULTI.
Industry payments across WA — which companies pay providers there.
